Wall Street Finance [WSFIN] vs Entero Healthcare [ENTERO] Detailed Stock Comparison

Wall Street Finance

Entero Healthcare
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Wall Street Finance wins in 8 metrics, Entero Healthcare wins in 8 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Wall Street Finance | Entero Healthcare | Better |
---|---|---|---|
P/E Ratio (TTM) | -18.70 | 49.64 | Wall Street Finance |
Price-to-Book Ratio | 2.92 | 2.95 | Wall Street Finance |
Debt-to-Equity Ratio | 1.49 | 21.76 | Wall Street Finance |
PEG Ratio | 1.34 | 1.30 | Entero Healthcare |
EV/EBITDA | -29.78 | 26.36 | Wall Street Finance |
Profit Margin (TTM) | 0.88% | 1.90% | Entero Healthcare |
Operating Margin (TTM) | -0.27% | 2.94% | Entero Healthcare |
EBITDA Margin (TTM) | N/A | 2.94% | N/A |
Return on Equity | -17.87% | 5.36% | Entero Healthcare |
Return on Assets (TTM) | -7.97% | 3.51% | Entero Healthcare |
Free Cash Flow (TTM) | N/A | $-881.80M | N/A |
1-Year Return | -51.26% | -17.14% | Entero Healthcare |
Price-to-Sales Ratio (TTM) | 0.04 | 0.94 | Wall Street Finance |
Enterprise Value | $954.77M | $51.35B | Entero Healthcare |
EV/Revenue Ratio | 0.05 | 0.95 | Wall Street Finance |
Gross Profit Margin (TTM) | 16.89% | 9.94% | Wall Street Finance |
Revenue per Share (TTM) | $1,828 | $1,242 | Wall Street Finance |
Earnings per Share (Diluted) | $-3.81 | $23.55 | Entero Healthcare |
Wall Street Finance vs Entero Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Wall Street Finance | -0.87% | 0.28% | -4.47% | -15.00% | -14.94% | -41.80% |
Entero Healthcare | 1.40% | -5.30% | -10.01% | -2.28% | -1.16% | -21.13% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Wall Street Finance | -51.26% | 115.89% | 349.30% | 118.21% | 77.75% | 172.39% |
Entero Healthcare | -17.14% | -1.50% | -1.50% | -1.50% | -1.50% | -1.50% |
News Based Sentiment: Wall Street Finance vs Entero Healthcare
Wall Street Finance
News based Sentiment: MIXED
WSFIN experienced a mixed month with a positive dividend announcement countered by a declining share price and changes in promoter holding. The upcoming AGM and annual report are critical events that will shape the investment narrative, making this a moderately important month for investors.
Entero Healthcare
News based Sentiment: MIXED
Entero Healthcare Solutions is demonstrating strong financial performance with impressive revenue and profit growth, as evidenced by the Q2 FY25 and Q1 FY26 results. However, the stock has experienced significant volatility and a decline over the past six months, creating a mixed investment picture. The upcoming investor meetings and Q3 2026 earnings report will be crucial to watch.
Performance & Financial Health Analysis: Wall Street Finance vs Entero Healthcare
Metric | WSFIN | ENTERO |
---|---|---|
Market Information | ||
Market Cap | ₹826.36M | ₹49.85B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 1,249 | 106,975 |
90 Day Avg. Volume | 617 | 83,414 |
Last Close | ₹60.35 | ₹1,148.20 |
52 Week Range | ₹58.35 - ₹137.95 | ₹1,080.00 - ₹1,584.25 |
% from 52W High | -56.25% | -27.52% |
All-Time High | ₹146.45 (May 20, 2024) | ₹1,584.25 (Nov 04, 2024) |
% from All-Time High | -58.79% | -27.52% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.19% | 0.28% |
Quarterly Earnings Growth | 0.45% | 0.38% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.02% |
Operating Margin (TTM) | 0.00% | 0.03% |
Return on Equity (TTM) | -0.18% | 0.05% |
Debt to Equity (MRQ) | 1.49 | 21.76 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹9.86 | ₹396.70 |
Cash per Share (MRQ) | N/A | ₹73.09 |
Operating Cash Flow (TTM) | ₹-85,830,000 | ₹-1,784,990,000 |
Levered Free Cash Flow (TTM) | ₹-44,189,000 | ₹948.20M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Wall Street Finance vs Entero Healthcare
Metric | WSFIN | ENTERO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -18.70 | 49.64 |
Forward P/E | N/A | 22.40 |
PEG Ratio | 1.34 | 1.30 |
Price to Sales (TTM) | 0.04 | 0.94 |
Price to Book (MRQ) | 2.92 | 2.95 |
Market Capitalization | ||
Market Capitalization | ₹826.36M | ₹49.85B |
Enterprise Value | ₹954.77M | ₹51.35B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.05 | 0.95 |
Enterprise to EBITDA | -29.78 | 26.36 |
Risk & Other Metrics | ||
Beta | N/A | N/A |
Book Value per Share (MRQ) | ₹9.86 | ₹396.70 |
Financial Statements Comparison: Wall Street Finance vs Entero Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | WSFIN | ENTERO |
---|---|---|
Revenue/Sales | N/A | ₹14.04B |
Cost of Goods Sold | N/A | ₹12.64B |
Gross Profit | N/A | ₹1.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | N/A | ₹412.02M |
EBITDA | N/A | ₹558.96M |
Pre-Tax Income | N/A | ₹363.63M |
Income Tax | N/A | ₹61.31M |
Net Income (Profit) | N/A | ₹302.32M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | WSFIN | ENTERO |
---|---|---|
Cash & Equivalents | N/A | ₹2.29B |
Total Current Assets | N/A | ₹20.76B |
Total Current Liabilities | N/A | ₹8.45B |
Long-Term Debt | N/A | ₹670.18M |
Total Shareholders Equity | N/A | ₹17.70B |
Retained Earnings | N/A | ₹638.28M |
Property, Plant & Equipment | N/A | ₹1.64B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | WSFIN | ENTERO |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | WSFIN | ENTERO |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 1,249 | 106,975 |
Average Daily Volume (90 Day) | 617 | 83,414 |
Shares Outstanding | 11.60M | 43.51M |
Float Shares | N/A | 11.24M |
% Held by Insiders | N/A | 0.63% |
% Held by Institutions | N/A | 0.21% |
Dividend Analysis & Yield Comparison: Wall Street Finance vs Entero Healthcare
Metric | WSFIN | ENTERO |
---|---|---|
Last 12-Month Dividend | ₹0.00 | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | ₹0.00 | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | ₹0.00 | N/A |
Ex-Dividend Date | N/A | N/A |